Dr. Reddy’s to focus on complex products as growth drivers to offset Revlimid revenue loss
Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1s (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...
Kabra Jewels Ltd News
Get the latest news today on Kabra Jewels Ltd. Follow Business Standard for the complete news coverage and key information about the Kabra Jewels Ltd.